Coronavirus update

March 27, 2020

Prime Therapeutics is closely monitoring the coronavirus (COVID-19) outbreak. We know that our members rely on us to get the medicine they need. We stand ready to meet their needs. We’ve made temporary changes to prior approval requirements to ensure members have continued access to their medications.

We have also taken steps to protect and safeguard our employees. Most of our employees have transitioned to working from home. As a company, we are fortunate to have technology that allows us to do our work remotely and employees who are dedicated to serving our members and doing the right thing. 

Several of the states where Prime has operations have now issued stay-at-home/shelter-in-place directives. Rest assured that Prime is considered an essential business and is prepared with the documentation necessary to allow employees to continue perform their work serving members and monitoring drug availability. We continue to monitor for additional stay-at-home directives and are prepared to comply without an interruption in service.

If you are a member who needs information about your own benefits, please see MyPrime.com for more information about your specific health plan.